237 related articles for article (PubMed ID: 9575352)
1. The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist.
Wieczorek Z; Kluczyk A; Slon-Usakiewicz JJ; Siemion IZ
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):123-9. PubMed ID: 9575352
[TBL] [Abstract][Full Text] [Related]
2. A hexapeptide VTKFYF from C-terminal part of interleukin-1 receptor antagonist, an inhibitor of IL-1-IL-1 receptor interaction.
Wieczorek Z; Kluczyk A; Słoń-Usakiewicz JJ; Siemion IZ
Pol J Pharmacol; 1997; 49(2-3):107-17. PubMed ID: 9437757
[TBL] [Abstract][Full Text] [Related]
3. Anti-IL-1 activity of peptide fragments of IL-1 family proteins.
Siemion IZ; Kluczyk A; Wieczorek Z
Peptides; 1998; 19(2):373-82. PubMed ID: 9493871
[TBL] [Abstract][Full Text] [Related]
4. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.
Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G
J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory activity of oligopeptides related to interleukin 1 receptor antagonist sequence.
Kluczyk A; Siemion IZ; Słoń-Usakiewicz JJ; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):427-33. PubMed ID: 9437498
[TBL] [Abstract][Full Text] [Related]
6. Anion binding and controlled aggregation of human interleukin-1 receptor antagonist.
Raibekas AA; Bures EJ; Siska CC; Kohno T; Latypov RF; Kerwin BA
Biochemistry; 2005 Jul; 44(29):9871-9. PubMed ID: 16026159
[TBL] [Abstract][Full Text] [Related]
7. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.
Schreuder H; Tardif C; Trump-Kallmeyer S; Soffientini A; Sarubbi E; Akeson A; Bowlin T; Yanofsky S; Barrett RW
Nature; 1997 Mar; 386(6621):194-200. PubMed ID: 9062194
[TBL] [Abstract][Full Text] [Related]
8. [Effect of intracerebroventricular injection of IL-1 beta on generation of immuno-suppressive factor in lymphocytes in stressed mice].
Li YF; Zuo YC; Shao L; Song DM; Ding GF; Fan SG
Yao Xue Xue Bao; 1995; 30(5):395-9. PubMed ID: 7660807
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor antagonism.
Nikolic-Paterson DJ; Lan HY; Atkins RC
Semin Nephrol; 1996 Nov; 16(6):583-90. PubMed ID: 9125803
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a low molecular weight isoform of IL-1 receptor antagonist.
Malyak M; Guthridge JM; Hance KR; Dower SK; Freed JH; Arend WP
J Immunol; 1998 Aug; 161(4):1997-2003. PubMed ID: 9712072
[TBL] [Abstract][Full Text] [Related]
11. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.
Svenson M; Nedergaard S; Heegaard PM; Whisenand TD; Arend WP; Bendtzen K
Eur J Immunol; 1995 Oct; 25(10):2842-50. PubMed ID: 7589081
[TBL] [Abstract][Full Text] [Related]
12. Cloning of equine interleukin 1 receptor antagonist and determination of its full-length cDNA sequence.
Howard RD; McIlwraith CW; Trotter GW; Nyborg JK
Am J Vet Res; 1998 Jun; 59(6):712-6. PubMed ID: 9622739
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
[TBL] [Abstract][Full Text] [Related]
14. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II.
Ruggiero P; Bossù P; Macchia G; Del Grosso E; Sabbatini V; Bertini R; Colagrande A; Bizzarri C; Maurizi G; Di Cioccio V; D'Andrea G; Di Giulio A; Frigerio F; Grifantini R; Grandi G; Tagliabue A; Boraschi D
J Immunol; 1997 Apr; 158(8):3881-7. PubMed ID: 9103457
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of interleukin-1 receptor antagonist on oleic acid-induced lung injury.
Sun D; Zhao M; Ma D; Liao S; Di C
Chin Med J (Engl); 1996 Jul; 109(7):522-6. PubMed ID: 9206098
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.
Hannum CH; Wilcox CJ; Arend WP; Joslin FG; Dripps DJ; Heimdal PL; Armes LG; Sommer A; Eisenberg SP; Thompson RC
Nature; 1990 Jan; 343(6256):336-40. PubMed ID: 2137200
[TBL] [Abstract][Full Text] [Related]
18. Competition between IL-1, IL-1ra and TGF-beta 1 modulates the response of the ELA4.NOB-1/CTLL bioassay: implications for clinical investigations.
Ashwood P; Harvey R; Verjee T; Wolstencroft R; Thompson RP; Powell JJ
Inflamm Res; 2004 Feb; 53(2):60-5. PubMed ID: 15021970
[TBL] [Abstract][Full Text] [Related]
19. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta.
Evans RJ; Bray J; Childs JD; Vigers GP; Brandhuber BJ; Skalicky JJ; Thompson RC; Eisenberg SP
J Biol Chem; 1995 May; 270(19):11477-83. PubMed ID: 7744786
[TBL] [Abstract][Full Text] [Related]
20. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.
Ricci S; Macchia G; Ruggiero P; Maggi T; Bossù P; Xu L; Medaglini D; Tagliabue A; Hammarström L; Pozzi G; Boraschi D
BMC Biotechnol; 2003 Sep; 3():15. PubMed ID: 13129437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
